United States · FDA National Drug Code directory

Dalfampridine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 67877-444_7359109d-e6d1-4e42-bb3b-746e8d5fb686
Product NDC: 67877-444
Form: TABLET, FILM COATED, EXTENDED RELEASE
Composition / generic term: Dalfampridine
Labeler: Ascend Laboratories, LLC
Marketing category: ANDA
Marketing start / end (source format): 20180731
Source listing expiry: 20271231

Source-listed ingredients

DALFAMPRIDINE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-444-05) · 67877-444-05
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-444-60) · 67877-444-60
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-444-90) · 67877-444-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →